141 related articles for article (PubMed ID: 1703988)
1. Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaemia virus.
Perryman LE; O'Rourke KI; Mason PH; McGuire TC
Immunology; 1990 Dec; 71(4):592-4. PubMed ID: 1703988
[TBL] [Abstract][Full Text] [Related]
2. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
[TBL] [Abstract][Full Text] [Related]
3. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.
Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; West M; Montelaro RC
Arch Virol; 1988; 98(3-4):213-24. PubMed ID: 2450529
[TBL] [Abstract][Full Text] [Related]
4. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies.
Ball JM; Rushlow KE; Issel CJ; Montelaro RC
J Virol; 1992 Feb; 66(2):732-42. PubMed ID: 1370556
[TBL] [Abstract][Full Text] [Related]
5. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
[TBL] [Abstract][Full Text] [Related]
6. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli.
Payne SL; Rushlow K; Dhruva BR; Issel CJ; Montelaro RC
Virology; 1989 Oct; 172(2):609-15. PubMed ID: 2552661
[TBL] [Abstract][Full Text] [Related]
7. Serologically silent, occult equine infectious anemia virus (EIAV) infections in horses.
Ricotti S; Garcia MI; Veaute C; Bailat A; Lucca E; Cook RF; Cook SJ; Soutullo A
Vet Microbiol; 2016 May; 187():41-49. PubMed ID: 27066707
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.
Montelaro RC; Robey WG; West MD; Issel CJ; Fischinger PJ
J Gen Virol; 1988 Jul; 69 ( Pt 7)():1711-7. PubMed ID: 2839603
[TBL] [Abstract][Full Text] [Related]
9. Hybridoma cell lines secreting monoclonal antibodies against equine infectious anemia virus.
Horenstein AL; Glait HM; Koss A
J Virol Methods; 1987 Feb; 15(3):177-85. PubMed ID: 2435751
[TBL] [Abstract][Full Text] [Related]
10. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
Tschetter JR; Byrne KM; Perryman LE; McGuire TC
Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus cross-reactive determinants present in the capsid protein of equine infectious anaemia virus.
Grund CH; Lechman ER; Issel CJ; Montelaro RC; Rushlow KE
J Gen Virol; 1994 Mar; 75 ( Pt 3)():657-62. PubMed ID: 7510329
[TBL] [Abstract][Full Text] [Related]
12. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.
Montelaro RC; Parekh B; Orrego A; Issel CJ
J Biol Chem; 1984 Aug; 259(16):10539-44. PubMed ID: 6206055
[TBL] [Abstract][Full Text] [Related]
13. Effect of two synthetic peptides mimicking conserved regions of equine infectious anemia virus proteins gp90 and gp45 upon cytokine mRNA expression.
Bailat AS; Soutullo AR; García MI; Veaute CM; Garcia L; Racca AL; Malan Borel IS
Arch Virol; 2008; 153(10):1909-15. PubMed ID: 18825485
[TBL] [Abstract][Full Text] [Related]
14. Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.
Jin S; Issel CJ; Montelaro RC
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1120-9. PubMed ID: 15539516
[TBL] [Abstract][Full Text] [Related]
15. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
Howe L; Leroux C; Issel CJ; Montelaro RC
J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
[TBL] [Abstract][Full Text] [Related]
16. Identification of gag precursor of equine infectious anaemia virus with monoclonal antibodies to the major viral core protein, p26.
Hussain KA; Issel CJ; Rwambo PM; Arnizaut AB; Ball JM; Schnorr KL; Montelaro RC
J Gen Virol; 1988 Jul; 69 ( Pt 7)():1719-24. PubMed ID: 2839604
[TBL] [Abstract][Full Text] [Related]
17. Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides.
Soutullo A; García MI; Bailat A; Racca A; Tonarelli G; Malan Borel I
Vet Immunol Immunopathol; 2005 Dec; 108(3-4):335-43. PubMed ID: 16105689
[TBL] [Abstract][Full Text] [Related]
18. Validation of an immunoblot assay employing an objective reading system and used as a confirmatory test in equine infectious anaemia surveillance programs.
Scicluna MT; Autorino GL; Cook SJ; Issel CJ; Cook RF; Nardini R
J Virol Methods; 2019 Apr; 266():77-88. PubMed ID: 30684508
[TBL] [Abstract][Full Text] [Related]
19. [Expression and immunogenicity of equine infectious anemia virus membrane protein GP90].
Dai CB; Xiao Y; Lu H; Shen RX; Shao YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):73-6. PubMed ID: 12870025
[TBL] [Abstract][Full Text] [Related]
20. Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.
Fraser DG; Oaks JL; Brown WC; McGuire TC
Immunology; 2002 Mar; 105(3):295-305. PubMed ID: 11918691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
